HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy, Tolerability, and Safety of Treatment With Perampanel in Pediatric Patients With Epilepsy Aged ≥4 Years: A Real-Life Observational Study.

Abstract
Purpose: The safety and effectiveness of perampanel in clinical settings involving Chinese pediatric patients are limited, as perampanel has only recently been approved for use in China, in September 2019. We aimed to evaluate the efficacy and tolerability of perampanel as an adjunctive therapy for pediatric patients with epilepsy aged ≥ 4 years in Xinjiang, Northwest China. Methods: Efficacy was assessed by measuring changes in seizure frequency at 3-, 6-, and 12-month follow-up compared with baseline. The baseline was 3 months before the addition of perampanel, and the seizure frequency was based on the patients' seizure diary. The safety and tolerability depended on the type and frequency of any adverse event during epilepsy treatment across all pediatric patients. Results: Overall, 67 pediatric patients from 2 different hospitals were enrolled in the study. Among the pediatric patients with seizures during the baseline period, the effective rates for all seizure types at 3, 6, and 12 months were 59.1%, 58.7%, and 57.4%, respectively. During perampanel treatment, 34 patients (50.7%) experienced at least 1 adverse reaction. Conclusion: Overall, this real-world retrospective study of pediatric patients validated that perampanel is an effective treatment option as an adjunctive therapy among pediatric patients with epilepsy aged ≥4 years.
AuthorsTing Zhao, Hong-Jian Li, Ji-Rong Feng, Hui-Lan Zhang, Jing Yu, Jie Feng, Ting-Ting Wang, Yan Sun, Lu-Hai Yu
JournalJournal of child neurology (J Child Neurol) Vol. 38 Issue 6-7 Pg. 414-421 (05 2023) ISSN: 1708-8283 [Electronic] United States
PMID37350050 (Publication Type: Observational Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • perampanel
  • Anticonvulsants
  • Pyridones
Topics
  • Humans
  • Child
  • Anticonvulsants (adverse effects)
  • Retrospective Studies
  • Epilepsy (drug therapy)
  • Seizures (drug therapy)
  • Pyridones (adverse effects)
  • Treatment Outcome
  • Drug Therapy, Combination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: